Can You Buy Progesterone? Prescription vs. OTC Options

Progesterone is available both over the counter and by prescription in the United States, but what you can buy without a doctor’s involvement is limited to topical creams and one progestin-only birth control pill. The stronger, more commonly prescribed forms of progesterone, including oral capsules, vaginal gels, and injectable preparations, all require a prescription. The distinction matters more than it might seem, because the OTC and prescription products differ not just in convenience but in how much hormone actually reaches your tissues and what medical conditions they can safely address.

What You Can Buy Without a Prescription

Two categories of progesterone-related products sit on store shelves or ship without a prescription. The first is OTC progesterone cream, which has been sold in the United States for decades as a cosmetic or dietary supplement rather than a drug. These creams typically contain progesterone derived from plant sources like wild yam or soy and are rubbed into the skin. Because they are classified as supplements or cosmetics, they do not go through the same approval process as pharmaceutical drugs, and their labeling cannot legally make specific medical claims.

The second OTC option is the progestin-only contraceptive pill Opill, which the FDA approved for over-the-counter sale in July 2023, making it the first daily oral contraceptive available without a prescription in the U.S. Opill contains norgestrel, a synthetic progestin, and retails for about $20 for a one-month supply or $50 for three months with no age restriction.¹ It is worth noting that Opill is a contraceptive, not a progesterone supplement. If you are looking for progesterone to support a pregnancy, manage menopause symptoms, or protect your uterine lining, Opill is not the product you need. It serves an entirely different purpose.

Do OTC Progesterone Creams Actually Work?

This is the question that makes the OTC-vs-prescription distinction genuinely complicated. OTC progesterone creams do raise progesterone levels in the body, but the picture of how much they deliver and where that progesterone ends up is surprisingly murky.

When researchers have measured serum (blood) levels after applying progesterone cream, the increases tend to look modest. In one study of postmenopausal women, mean serum progesterone concentrations ranged from about 1.6 to 3.3 ng/mL after regular application, with levels sustaining for at least eight hours and building over four weeks compared to two weeks of use.² Those numbers might sound low, and based on serum alone, they are. But serum levels tell only part of the story.

A randomized crossover study comparing progesterone cream to gel found that after topical application, progesterone levels measured in capillary blood (from a finger prick) were roughly 100 times higher than levels in standard venous blood draws, and saliva levels were about 10 times higher than serum.³ The researchers concluded that high capillary and saliva levels indicate substantial absorption and transport to tissues, and that relying on serum alone could lead clinicians to underestimate tissue exposure and inadvertently prescribe too much.

Perhaps the most provocative finding comes from a study that directly compared an OTC progesterone cream to an FDA-approved oral progesterone capsule at their respective labeled doses. When the researchers normalized for dose, the 24-hour progesterone exposure from the cream was not significantly different from the oral capsules. The study’s authors raised the concern that if long-term progesterone use carries health risks, selling a product that delivers comparable drug exposure without a prescription or medical supervision may not be appropriate.⁴

So the short version: OTC progesterone cream is not inert. It delivers real hormone to your body. But the lack of standardized dosing, variable absorption between individuals, and the difficulty of monitoring tissue levels make it a much less predictable tool than prescription progesterone.

Prescription Progesterone and What It’s Used For

Prescription progesterone comes in several forms, each suited to different clinical situations. Oral micronized progesterone, sold under brand names like Prometrium, is the most commonly prescribed version for menopause-related hormone therapy. “Micronized” just means the progesterone particles have been ground small enough to improve absorption through the gut. Vaginal progesterone, available as gels, suppositories, or inserts, is widely used in fertility treatments and early pregnancy support. Injectable progesterone, given as intramuscular shots, has been used in pregnancy support as well, though vaginal and oral forms have largely replaced it for many patients.

In menopause hormone therapy, progesterone’s primary job is protecting the uterine lining. Estrogen therapy alone stimulates the endometrium and raises the risk of endometrial hyperplasia and cancer. Progesterone counteracts that stimulation. Clinical guidelines specify that progestogen should be given for at least 12 to 14 days per month in cyclical regimens or daily in continuous combined regimens; shorter durations and lower doses are associated with increased risks of breakthrough bleeding, hyperplasia, and endometrial cancer.⁵ This is one reason OTC creams are considered unreliable for endometrial protection: without controlled dosing and monitoring, you cannot be confident the lining is adequately opposed.

In reproductive medicine, progesterone supports the uterine environment needed for embryo implantation and early pregnancy. Luteal phase support with progesterone is a standard part of in vitro fertilization protocols.⁶ For women with recurrent pregnancy loss, vaginal micronized progesterone started in the luteal phase has been linked to higher pregnancy success rates compared to no treatment, with one study reporting a rate of 68% versus 51% in controls.⁷

Oral Versus Vaginal Prescription Progesterone

If your doctor prescribes progesterone, the route of administration matters for side effects and daily experience, though outcomes are often similar. A randomized trial comparing oral to vaginal progesterone before embryo transfer found that oral administration produced higher blood levels of progesterone, yet clinical pregnancy rates, live birth rates, and miscarriage rates were not significantly different between the two routes.⁸ This makes sense biologically: vaginal progesterone bypasses the liver and delivers high local concentrations directly to the uterus, while oral progesterone goes through first-pass liver metabolism, which transforms some of it into metabolites with their own effects.

One of those metabolites, allopregnanolone, acts on the brain’s GABA receptors, which is why oral micronized progesterone tends to cause drowsiness. For many women, that sleepiness is actually welcome: oral progesterone taken at bedtime can improve sleep quality. But the same neurosteroid activity means oral progesterone is more likely to cause daytime fatigue, dizziness, and mood changes than the vaginal form, which largely avoids first-pass metabolism.⁹ Your doctor’s choice of route typically balances the clinical goal, your tolerance for side effects, and practical preferences about how you take your medication.

Why Micronized Progesterone Is Not the Same as Synthetic Progestins

The word “progesterone” is often used loosely, but the distinction between micronized progesterone (which is chemically identical to what your body makes) and synthetic progestins (lab-modified molecules that activate progesterone receptors but have different chemical structures) has real clinical consequences. Synthetic progestins such as medroxyprogesterone acetate, levonorgestrel, and norethisterone were the workhorses of earlier hormone therapy regimens. Micronized progesterone has increasingly replaced them in many settings, largely because of a better safety profile.

The most talked-about difference involves breast cancer risk. A systematic review and meta-analysis found that when combined with estrogen, micronized progesterone was associated with a roughly one-third lower breast cancer risk compared to synthetic progestins, with a relative risk of 0.67.¹⁰ An international expert panel reviewing the evidence concluded that estrogen combined with micronized progesterone does not appear to increase breast cancer risk for up to five years of use, though evidence beyond five years is more limited.¹¹

Beyond breast cancer, micronized progesterone appears to carry a more favorable metabolic and cardiovascular profile than many synthetic progestins. Some studies suggest it poses less risk for blood clots and has a more acceptable impact on cholesterol and blood sugar markers.⁹ None of this means micronized progesterone is risk-free; it means the type of progestogen your doctor chooses is a meaningful decision, not an interchangeable one.

Side Effects to Expect

Regardless of the form, progesterone use comes with side effects that vary by route and individual sensitivity. Oral micronized progesterone’s drowsiness is the most consistent effect and is generally managed by taking the dose at bedtime. The same neurosteroid activity that promotes sleep can also cause dizziness and, in some women, changes in mood. A controlled study found that progesterone administration was associated with increased confusion and fatigue, along with reduced confidence, even after accounting for placebo-related mood changes.¹²

Vaginal progesterone avoids most of the central nervous system effects but can cause local irritation, discharge, and occasional spotting. Injectable progesterone is associated with pain at the injection site and, over time, can cause local tissue reactions. For most women, side effects from any form are manageable and resolve after stopping the medication, but if you have a history of depression or premenstrual mood disorders, it is worth discussing this with your prescriber before starting oral progesterone, since the neurosteroid metabolites may affect you more strongly.

The Compounded “Bioidentical” Market

Between the OTC cream aisle and the standard prescription pharmacy, there is a third option that generates a lot of consumer interest: custom-compounded progesterone preparations, often marketed under the umbrella of “bioidentical hormone replacement therapy,” or BHRT. Compounding pharmacies mix progesterone into creams, troches, capsules, or sublingual drops in doses tailored to an individual patient, typically ordered by a practitioner.

The appeal is understandable. A qualitative study of women who chose compounded bioidentical hormones found two main sets of motivations. “Push” factors included fear about the safety of conventional hormone therapy, distrust of a medical system perceived as dismissive of their symptoms, and dissatisfaction with herbal supplements. “Pull” factors included the perception that compounded hormones are safer, more effective, and personalized to their bodies, accompanied by more attentive clinical care.¹³

The problem is that compounded preparations are not held to the same regulatory standards as FDA-approved drugs. Unlike Prometrium or other approved progesterone products, compounded formulations are not tested for batch-to-batch consistency, purity, or potency in any standardized way. Patients using custom-compounded progesterone creams may experience significant variability in how much hormone they actually receive from one refill to the next, leading to unpredictable effects and potential safety concerns.¹⁴ The term “bioidentical” itself is a marketing distinction, not a medical one. FDA-approved micronized progesterone is also bioidentical in the chemical sense; the molecule is the same. The difference is that the approved version has been tested for consistent delivery and safety in clinical trials.

Why Monitoring Topical Progesterone Is Tricky

One underappreciated issue with any form of topical progesterone, whether OTC cream or compounded preparation, is that standard blood tests may not reflect what is happening in your tissues. As the absorption studies described earlier showed, progesterone applied to the skin travels through the body in ways that do not always show up in a venous blood draw. Salivary progesterone levels rise significantly within 30 to 60 minutes of cream application and reach peak concentrations well above what serum levels would suggest.¹⁵

This creates a genuine clinical dilemma. A doctor checking your serum progesterone after you have been using a topical cream might see levels that look low and conclude the cream is not working, potentially adding more progesterone or switching you to a higher dose. Meanwhile, the actual tissue concentrations could be substantially higher. Some practitioners have begun using saliva or capillary blood testing to get a more accurate picture of topical progesterone delivery, but these methods are not yet standardized or widely accepted in mainstream clinical practice. If you are using any topical progesterone product, whether OTC or compounded, and your provider is monitoring your levels, it is worth asking which type of test they are using and whether it is appropriate for your delivery method.

How OTC Contraceptive Access Changed the Landscape

The FDA’s approval of Opill for OTC sale was a landmark moment for reproductive healthcare access in the U.S., and early data suggest it is shifting behavior. A study published in JAMA Network Open found that OTC availability of the contraceptive pill was associated with a roughly 32-percentage-point increase in women moving from no contraception to using the OTC pill, and a 41-percentage-point increase in women switching from less effective methods to the OTC pill.¹⁶ Another pharmaceutical company, Cadence, is working toward FDA approval of an OTC combined estrogen-progestin contraceptive called Zena, though that effort is further behind in the regulatory process.¹

These developments are about contraception, not hormone supplementation, but they reflect a broader trend of expanding OTC access to hormonal products that were previously prescription-only. Whether that trend eventually extends to progesterone for non-contraceptive uses, such as menopause symptom management or sleep support, remains an open question. For now, the regulatory line is clear: if you want progesterone for anything beyond what an OTC cream or contraceptive pill provides, you need a prescription. Given the complexities of dosing, monitoring, and the meaningful differences between progesterone types, that requirement exists for reasons the research continues to reinforce.